267 related articles for article (PubMed ID: 25371354)
1. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
Bashir MR; Huang R; Mayes N; Marin D; Berg CL; Nelson RC; Jaffe TA
J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354
[TBL] [Abstract][Full Text] [Related]
2. How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.
Sofue K; Sirlin CB; Allen BC; Nelson RC; Berg CL; Bashir MR
J Magn Reson Imaging; 2016 Jun; 43(6):1337-45. PubMed ID: 26559157
[TBL] [Abstract][Full Text] [Related]
3. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation.
Rosenkrantz AB; Campbell N; Wehrli N; Triolo MJ; Kim S
Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785
[TBL] [Abstract][Full Text] [Related]
4. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
Fowler KJ; Karimova EJ; Arauz AR; Saad NE; Brunt EM; Chapman WC; Heiken JP
Transplantation; 2013 Jun; 95(12):1506-11. PubMed ID: 23778569
[TBL] [Abstract][Full Text] [Related]
5. Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models.
Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
J Magn Reson Imaging; 2016 Feb; 43(2):373-83. PubMed ID: 26119393
[TBL] [Abstract][Full Text] [Related]
6. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.
Davenport MS; Khalatbari S; Liu PS; Maturen KE; Kaza RK; Wasnik AP; Al-Hawary MM; Glazer DI; Stein EB; Patel J; Somashekar DK; Viglianti BL; Hussain HK
Radiology; 2014 Jul; 272(1):132-42. PubMed ID: 24555636
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
8. Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.
Barth BK; Donati OF; Fischer MA; Ulbrich EJ; Karlo CA; Becker A; Seifert B; Reiner CS
Acad Radiol; 2016 Sep; 23(9):1145-53. PubMed ID: 27174029
[TBL] [Abstract][Full Text] [Related]
9. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
[TBL] [Abstract][Full Text] [Related]
10. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
Ehman EC; Behr SC; Umetsu SE; Fidelman N; Yeh BM; Ferrell LD; Hope TA
Abdom Radiol (NY); 2016 May; 41(5):963-9. PubMed ID: 27193793
[TBL] [Abstract][Full Text] [Related]
11. Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.
Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM
J Comput Assist Tomogr; 2018; 42(1):155-161. PubMed ID: 28806321
[TBL] [Abstract][Full Text] [Related]
12. Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
Fowler KJ; Tang A; Santillan C; Bhargavan-Chatfield M; Heiken J; Jha RC; Weinreb J; Hussain H; Mitchell DG; Bashir MR; Costa EAC; Cunha GM; Coombs L; Wolfson T; Gamst AC; Brancatelli G; Yeh B; Sirlin CB
Radiology; 2018 Jan; 286(1):173-185. PubMed ID: 29091751
[TBL] [Abstract][Full Text] [Related]
13. Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.
Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
Acad Radiol; 2016 Mar; 23(3):344-52. PubMed ID: 26777590
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
Kierans AS; Song C; Gavlin A; Roudenko A; Lu L; Askin G; Hecht EM
AJR Am J Roentgenol; 2020 Nov; 215(5):1085-1092. PubMed ID: 32877248
[No Abstract] [Full Text] [Related]
15. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
[TBL] [Abstract][Full Text] [Related]
16. Liver Imaging Reporting and Data System Version 2018: Impact on Categorization and Hepatocellular Carcinoma Staging.
Chernyak V; Flusberg M; Berman J; Fruitman KC; Kobi M; Fowler KJ; Sirlin CB
Liver Transpl; 2019 Oct; 25(10):1488-1502. PubMed ID: 31344753
[TBL] [Abstract][Full Text] [Related]
17. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
[No Abstract] [Full Text] [Related]
18. Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm.
Becker AS; Barth BK; Marquez PH; Donati OF; Ulbrich EJ; Karlo C; Reiner CS; Fischer MA
Eur J Radiol; 2017 Jan; 86():33-40. PubMed ID: 28027763
[TBL] [Abstract][Full Text] [Related]
19. Does quantitative assessment of arterial phase hyperenhancement and washout improve LI-RADS v2018-based classification of liver lesions?
Stocker D; Becker AS; Barth BK; Skawran S; Kaniewska M; Fischer MA; Donati O; Reiner CS
Eur Radiol; 2020 May; 30(5):2922-2933. PubMed ID: 32020398
[TBL] [Abstract][Full Text] [Related]
20. Comparison of LI-RADS with other non-invasive liver MRI criteria and radiological opinion for diagnosing hepatocellular carcinoma in cirrhotic livers using gadoxetic acid with histopathological explant correlation.
Clarke CGD; Albazaz R; Smith CR; Rowe I; Treanor D; Wyatt JI; Sheridan MB; Guthrie JA
Clin Radiol; 2021 May; 76(5):333-341. PubMed ID: 33461746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]